astrazeneca_logo_building

AstraZeneca’s medicine approved under China’s Priority Review

March 27, 2017
Sales and Marketing AstraZeneca, Tagrisso, lung cancer

AstraZeneca has been boosted by the news that its drug, Tagrisso, has become its first drug to be approved under …

pills-384846_960_720

Five worrying facts about fake medicine

March 27, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Fake medicine, counterfeit medicine, falsified medicine

One million people die from fake drugs every year, with the worst continent being Africa where a suspected 200,000 die …

merck_kgaa_pyramid_use_with_credit

Merck KGaA and Pfizer enter the immunotherapy market with Bavencio

March 27, 2017
Sales and Marketing Bavencio, Merck KGaA, Pfizer

Merck KGaA and Pfizer have won approval for the fourth immunotherapy treatment to enter the market, with an indication in …

Lilly promises $850 million investment in message to White House

March 27, 2017
Manufacturing and Production, Sales and Marketing Eli Lilly, President trump, lilly

Eli Lilly’s latest press release indicated that it would be spending $850 million in developing its worldwide US operations, particularly …

4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

March 24, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

With the weekend on the horizon and a new issue of Pharmafocus hitting press, we review the most read, shared …

shutterstock_204190579

Cancer Research UK announces £10m pancreatic cancer project

March 24, 2017
Medical Communications, Research and Development Cancer Research UK, Pancreatic cancer

Cancer Research UK has revealed a £10 million investment into PRECISION-Panc, a pancreatic cancer-focused project which aims to improve patient …

australia-1157502_960_720

A patent analytics study of the Australian pharmaceutical industry

March 24, 2017
Medical Communications Australia, patent, pharmaceutical

This report provides an analysis of the Australian pharmaceutical and biopharmaceutical industry through the lens of patents. By using the …

mouse

Research found to reverse signs of ageing in mice

March 24, 2017
Medical Communications, Research and Development Aging

A new study has emerged that reveals another clue into the process of ageing and how, on a cellular level, …

Sanofi looks to close $1 billion deal Flexion

March 24, 2017
Medical Communications, Sales and Marketing Sanofi, flexion therapeutics, osteo

According to reports emerging, Sanofi may be on the verge of closing a deal with Burlington-based biotech, Flexion Therapeutics. The …

george_masoura_drugdev_vice_president_business_development_europe_0

DrugDev signs up George Masoura as Vice President of Business Development

March 23, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment

DrugDev has announced the appointment of George Masoura who has joined the company as Vice President, Business Development, Europe to …

Advent reportedly backs out of bid for Pfizer’s Brazil plant

March 23, 2017
Sales and Marketing Brazil, Pfizer, generics

It has been reported that Advent International Corp has pulled out of bidding for Pfizer’s stake in Brazilian generics manufacturer, …

injection-519388_960_720

Injectable drug market to grow to $625 billion worldwide by 2021

March 23, 2017
Sales and Marketing injectable drugs, injectables

New data released by intelligence firm MarketsandMarkets indicates that the global injectable drug market is set to reach $625 billion …

india_flag

Drug prices set to increase on ‘essential medicines’ list in India

March 23, 2017
Sales and Marketing Indian

The annual review of drug prices will see the price of drugs, on the National List of Essential Medicines, increase …

shutterstock_146497481

GSK and Regeneron partner with Biobank to analyse 500,000 genetic profiles

March 23, 2017
Research and Development Biobank, GSK, Regeneron

GlaxoSmithKline and Regeneron Pharmaceuticals are to band together in a joint effort with UK Biobank – “the world’s most detailed …

shire_image

Shire’s drug picked up from Baxalta given fast track designation

March 23, 2017
Research and Development, Sales and Marketing Shire, rare diseases

Shire has announced that its drug, SHP655, has received a fast track designation based on pre-clinical trials and positive results …

fda2outsideweb

FDA approves first Parkinson’s treatment in a decade

March 22, 2017
Research and Development, Sales and Marketing FDA, Parkinson's, Xadago

The FDA has approved Xadago (safinamide) as a supplementary treatment for Parkinson’s in patients currently taking levodopa/carbidopa and who are …

shutterstock_292920209

Alternative treatment cures rare blood disease for first time

March 22, 2017
Research and Development congenital dyserythropoietic anaemia

A Chicago man has become the first person ever documented to be cured of congenital dyserythropoietic anaemia (CDA), a rare …

gsk_boronia_australia

GSK begins £92 million expansion of UK site

March 22, 2017
Manufacturing and Production, Research and Development GSK, UK

GSK has officially broken ground on the expansion of its site in County Durham. The expanded site will be an …

heartbeat

Novartis heart failure drug sinks at Phase 3 trials

March 22, 2017
Research and Development Acute heart failure, Novartis, serelaxin

Novartis’ serelaxin was once thought to be the major hope for its cardiovascular pipeline – analysts projected it to become …

Novartis’ psoriasis drug allows some patients to go into remission

March 21, 2017
Research and Development Cosentyx, Novartis, psoriasis

Novartis released data on patient’s reaction to Cosentyx for the treatment of psoriasis, finding that as many as 21% of …

The Gateway to Local Adoption Series

Latest content